The companies said their long-term goal is to develop and offer more digital health tools "through a multi-partner ecosystem" as well as advocate for reimbursement options.
MobiHealthNews)
Kaiku Health, maker of an oncology-focused platform that collected patient-reported outcomes, is teaming up with pharma giant Novartis on a new initiative to help monitor and manage melanoma.
The companies will zero in on creating a remote monitoring and support network for patients receiving a specific drug combination, known as BRAF and MEK inhibitors, that aims to treat melanoma. As part of the program, the pair will develop a new tool on Kaiku s platform to track the symptoms of patients taking the medications and provide a management guide and patient-education tools.
Caregivers will get an automatic notification if a patient is reporting worsening symptoms in order to intervene. The new program will roll out in Europe first, starting in Germany, Netherlands, Switzerland and Italy in May 2021.